tiprankstipranks
Trending News
More News >
Arcus Biosciences Inc (RCUS)
NYSE:RCUS
US Market

Arcus Biosciences (RCUS) Income Statement

Compare
538 Followers

Arcus Biosciences Income Statement

Last quarter (Q4 2025), Arcus Biosciences's total revenue was $33.00M, an increase of 26.92% from the same quarter last year. In Q4, Arcus Biosciences's net income was $-98.00M. See Arcus Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 247.00M$ 258.00M$ 117.00M$ 112.00M$ 383.00M
Gross Profit
$ 237.00M$ 258.00M$ 117.00M$ 112.00M$ 383.00M
Operating Expenses
$ 623.00M$ 588.00M$ 457.00M$ 392.00M$ 329.00M
Depreciation and Amortization
$ 10.00M$ 10.00M$ 8.00M$ 6.00M$ 4.00M
EBITDA
$ -335.00M$ -269.00M$ -291.00M$ -258.00M$ 59.00M
Operating Income
$ -386.00M$ -330.00M$ -340.00M$ -280.00M$ 54.00M
Other Income/Expenses
$ 33.00M$ 47.00M$ 39.00M$ 14.00M$ 1.00M
Pretax Income
$ -353.00M$ -283.00M$ -301.00M$ -266.00M$ 55.00M
Net Income
$ -353.00M$ -283.00M$ -307.00M$ -267.00M$ 53.00M
Per Share Metrics
Basic EPS
$ -3.29$ -3.14$ -4.15$ -3.71$ 0.76
Diluted EPS
$ -3.29$ -3.14$ -4.15$ -3.71$ 0.71
Weighted Average Shares Outstanding
107.40M 90.10M 74.00M 72.00M 69.35M
Weighted Average Shares Outstanding (Diluted)
107.40M 90.10M 74.00M 72.00M 73.97M
Currency in USD

Arcus Biosciences Earnings and Revenue History